Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Dechra Pharmaceuticals Plc LSE:DPH London Ordinary Share GB0009633180 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  24.00 0.69% 3,498.00 3,502.00 3,504.00 3,520.00 3,470.00 3,500.00 547,964 16:35:06
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 515.1 40.9 32.9 106.4 3,789

Dechra Pharmaceuticals PLC Annual Financial Report

22/09/2020 7:00am

UK Regulatory (RNS & others)


Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart


From Sep 2020 to Oct 2020

Click Here for more Dechra Pharmaceuticals Charts.

TIDMDPH

RNS Number : 6481Z

Dechra Pharmaceuticals PLC

22 September 2020

22 September 2020

Dechra (R) Pharmaceuticals PLC

(the Company)

Annual Financial Report

The Company announced its Preliminary Results on 7 September 2020 in accordance with the financial reporting obligations of the Disclosure and Transparency Rules.

Copies of the Annual Report and Accounts for the year ended 30 June 2020, Notice of Annual General Meeting and Proxy Form have now been mailed to shareholders.

In accordance with Listing Rule 9.6.1 a copy of the Annual Financial Report and Notice of Meeting has been submitted to the FCA document viewing facility https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

The Annual Report and Accounts, Notice of Annual General Meeting and information relating to the voting rights of Shareholders (as required by section 311A of the Companies Act 2006) are available to view on the Company's website www.dechra.com . Further copies of the Annual Report and Accounts are available from the Company's registered office at:

24 Cheshire Avenue

Cheshire Business Park

Lostock Gralam

Northwich

CW9 7UA

Enquiries:

Melanie Hall, Company Secretary

Dechra Pharmaceuticals PLC

Tel: +44 (0) 1606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ACSEANNFAEPEEFA

(END) Dow Jones Newswires

September 22, 2020 02:00 ET (06:00 GMT)

1 Year Dechra Pharmaceuticals Chart

1 Year Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart

1 Month Dechra Pharmaceuticals Chart
ADVFN Advertorial
Your Recent History
LSE
DPH
Dechra Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201020 21:56:14